Sinovac Also Receives OK for EV71 Vaccine Trials

Sinovac Biotech was granted SFDA approval to begin clinical trials of an inactivated vaccine for EV71, also known as Hand, Foot and Mouth Disease (HFMD). Yesterday, China Biologic also announced approval for trials of a similar HFMD vaccine. Sinovac, which filed for an NDA in December 2009, has been waiting for a year for official permission to begin the clinical phase of development. More details.... Stock Symbol: (NSDQ: SVA)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.